
Escolha o seu rótulo
visível diretamente no frascoRelatório laboratorial
PDF- Testado
- Letrozol (Femara) 2.5mg × 100 Tabs
- Laboratório
- Analiza Białek
- Data
- October 2026
- Resultado
- 2.72 mg per tablet (2.5 mg label)
- N.º da encomenda
- Palavra-passe
Testado de forma independente, verificável com a palavra-passe diretamente no laboratório.
Letrozol (Femara)
PCT & AI
- Testado em laboratório
- Enviado da Alemanha
Encomenda
- DHL com seguimento
- Embalagem discreta
Num relance
Letrozol (Femara) em números
Os valores-chave da nossa enciclopédia. Arraste o ponto ao longo da curva para ver quanto resta após uma dose, segundo o cálculo.
Entrada completa da enciclopédiaHow long does it stay in the body?
Share left after one dose, calculated with a half-life of ~3 days
Simplified model without an absorption phase, half-life from the TPD lexicon. The lexicon gives 2 to 4 days, we calculate with the middle.
Half-life
about2-4days
- Class
- Aromatase inhibitornon-steroidal, reversible
- Use
- Oral1-2x per week
- Sizes
- 2.5 mg2 sizes in the shop
What studies show
All 2 sources in the lexiconLetrozole vs tamoxifen in postmenopausal breast cancer (BIG 1-98) (opens in a new tab)
BIG 1-98 Collaborative Group, NEJM, 2005- over99 %Geisler et al., Journal of Clinical Oncology, 2002
Avaliações
O que dizem os clientes
Apenas encomendas reais que incluíam Letrozol (Femara).
Todas as avaliaçõesConhecimento
Tudo sobre Letrozol (Femara)
Informação detalhada disponível em breve.
Is letrozole approved?
Yes. In the USA letrozole has been approved as a prescription tablet since 25 July 1997 and ChEMBL lists phase 4 as the highest phase. The large studies concern breast cancer after menopause.
How much does letrozole lower estrogens?
In a study with 12 women who took both drugs one after the other, letrozole suppressed whole-body estrogen production by more than 99.1 percent and anastrozole by 97.3 percent. Estradiol in the blood fell by 87.8 percent with letrozole and estrone sulfate by 98.0 percent.
What did BIG 1-98 show?
Over 8,000 postmenopausal women with hormone-sensitive breast cancer received letrozole or tamoxifen. After five years an estimated 84.0 against 81.4 percent were free of recurrence and the risk of recurrence fell by 19 percent. In return skeletal and cardiac events as well as raised cholesterol were more common with letrozole.
What is known in PCOS?
In a study of 750 women with PCOS trying to conceive letrozole led to a live birth more often than clomiphene (27.5 against 19.1 percent) and to ovulation more often. Hot flushes were more common with clomiphene, fatigue and dizziness with letrozole.
What about bone and blood lipids?
Less estrogen means less protection for bone. In MA.17 5.8 percent on letrozole and 4.5 percent on placebo received a new osteoporosis diagnosis, the difference was not significant. In BIG 1-98 raised cholesterol was more common with letrozole.
How long does letrozole stay in the body?
The US label gives a terminal elimination half-life of about 2 days. According to the label a steady level is only reached after 2 to 6 weeks of daily use.
Comparações
Como se compara
Relacionados
Produtos relacionados
Clomid (Clomifen)
Medicamentos · Pós-ciclo e inibidores da aromatase Pós-ciclo e inibidores da aromatase
2 tamanhos
Tamoxifen (Nolvadex)
Medicamentos · Pós-ciclo e inibidores da aromatase Pós-ciclo e inibidores da aromatase
2 tamanhos
Testado em laboratório
Aromasin (Exemestane)
Medicamentos · Pós-ciclo e inibidores da aromatase Pós-ciclo e inibidores da aromatase
2 tamanhos
Arimidex (Anastrozole)
Medicamentos · Pós-ciclo e inibidores da aromatase Pós-ciclo e inibidores da aromatase
2 tamanhos
Letrozol (Femara)
